MUCORMYCOSIS AMONG COVID-19 HOSPITALIZED PATIENTS DURING PANDEMIC WAVE 2 IN INDIA: A CASE SERIES
Critical Care Medicine
; 50:89-89, 2022.
Article
in English
| Academic Search Complete | ID: covidwho-1590881
ABSTRACT
Sino-nasal mucormycosis was predominant and affected 24 (61%) patients, 7 (18%) patients had rhino-cerebral Mucormycosis, and 5 (13%) patient had additional peripheral nervous system involvement. B Objective:
b Mucormycosis is not a new diagnosis but it has high incidence among COVID-19 patients in India during second wave of pandemic. [Extracted from the article] Copyright of Critical Care Medicine is the property of Lippincott Williams & Wilkins and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full . (Copyright applies to all s.)
Full text:
Available
Collection:
Databases of international organizations
Database:
Academic Search Complete
Language:
English
Journal:
Critical Care Medicine
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS